Correlation Between Scpharmaceuticals and Dermata Therapeutics

Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scpharmaceuticals and Dermata Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Dermata Therapeutics.

Diversification Opportunities for Scpharmaceuticals and Dermata Therapeutics

0.54

Correlation Coefficient

Scpharmaceuticals  Dermata Therapeutics

Very weak diversification

The 3 months correlation between Scpharmaceuticals and Dermata is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and Dermata Therapeutics

Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.37 times more return on investment than Dermata Therapeutics. However, Scpharmaceuticals is 2.68 times less risky than Dermata Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Dermata Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  697.00  in Scpharmaceuticals on August 13, 2024 and sell it today you would lose (276.00) from holding Scpharmaceuticals or give up 39.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Scpharmaceuticals  vs.  Dermata Therapeutics

Scpharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Dermata Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Scpharmaceuticals and Dermata Therapeutics

The main advantage of trading using opposite Scpharmaceuticals and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.

The idea behind Scpharmaceuticals and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.